BSECompany Update11 Aug 2026 · 11 Aug 2026, 09:02 pm

Pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you ....

Gaudium IVF and Women Health Ltd · 544709

✦ AI SummaryResults

Gaudium IVF and Women Health Ltd has scheduled an earnings conference call to discuss its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The call is scheduled for August 14, 2026, at 2:00 P.M. IST. The company has provided details of the call, including a pre-registration link and international toll-free numbers.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Gaudium IVF and Women Health Ltd - 544709 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Attachments (1)

📄

bcd51f9e-519b-4357-9969-5341bf97b705.pdf

pdf

Download →
View document text
gaudium® IVF Delivering Motherhood Dreams August 11, 2026 BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Exchange Plaza, C-1, Block G, Bandra Kurla Towers, Dalal Street, Fort, Complex, Bandra (E), Mumbai — 400051, Mumbai — 400001, Maharashtra Maharashtra Scrip Code — 544709 Symbol - GAUDIUMIVF ISIN: INEOP8B01020 ISIN: INEOP8B01020 Subject: Intimation of Q1 & FY 2027 Earnings Call Ref: Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 Dear Sir/Ma’am Pursuant to Regulation 30 read with Schedule IIT of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that an Earnings Conference Call to discuss the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30, 2026, is scheduled for Friday, August 14, 2026, at 02:00 P.M. IST. The details pertaining to the said call are enclosed herewith and the same will also be available on the website of the Company at https://www.gaudiumivfcentre.com/ We request you to kindly take the same on record. Thanking you, Yours faithfully. For and on behalf of Gaudium IVF and Women Health Limited (Formerly known as Gaudium IVF and Women Health Private Limited) Naveen Kumar Company Secretary and Compliance Officer Membership No: A69788 Encl: a/a Gaudium IVF and Women Health Limited (Formerly known as Gaudium IVF and Women Health Pvt. Ltd.) Registered Office : B1/51, Janakpuri, New Delhi- 110058 | Ph: 011-4885 8585 CIN : L85100DL2015PLC278296 Email : info@gaudiumivfcentre.com Website : www.gaudiumivfcentre.com -[E]3 The Management of Gaudium IVF and Women Health Limited Invites you to the Q1 FY27 To discuss the performance for the quarter ended June 30, 2026 Date: Friday, 14th August 2026 Time: 02:00 PM IST Option 1 Pre- registration link Click Here Direct Call Universal Access Number +91 22 6280 1102 / +91 22 7115 8003 Option 2 International Toll-Free Numbers Dial-in through USA 18667462133 Operator Assistance UK 08081011573 Hong Kong 800964448 Singapore 8001012045 Participants are requested to dial-in few minutes in advance Management Participants Dr. Manika Khanna, Mr. Vishad Khanna, Mr. Rakesh K. Sharma Chairperson & Managing Director Non-Executive Director Chief Financial Officer For more information, please contact: Rushabh Shah / Anand Venugopal Mobile: +91 8082180182 / +91 7021852071 Email id: rushabh.shah@adfactorspr.com / anand.venugopal@adfactorspr.com